BVF as of June 30, 2014
Portfolio Holdings for BVF
BVF holds 29 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 22.3 | $141M | 9.2M | 15.33 | |
| Ligand Pharmaceuticals In (LGND) | 18.6 | $118M | 1.9M | 62.29 | |
| Array BioPharma | 10.6 | $67M | 15M | 4.56 | |
| Chemocentryx | 7.6 | $48M | 8.2M | 5.85 | |
| Receptos | 6.1 | $39M | 911k | 42.60 | |
| Oncothyreon | 5.0 | $32M | 9.9M | 3.24 | |
| Targacept | 4.8 | $30M | 6.7M | 4.51 | |
| Exelixis Inc cnv | 4.0 | $25M | 30M | 0.85 | |
| Five Prime Therapeutics | 3.1 | $20M | 1.3M | 15.55 | |
| Oncomed Pharmaceuticals | 3.0 | $19M | 826k | 23.30 | |
| Array Biopharma Inc note 3.000% 6/0 | 2.9 | $19M | 19M | 1.00 | |
| Regado Biosciences | 2.8 | $18M | 2.6M | 6.79 | |
| Qlt | 2.3 | $15M | 2.4M | 6.18 | |
| Cytokinetics (CYTK) | 1.0 | $6.3M | 1.3M | 4.78 | |
| Trevena | 1.0 | $6.3M | 1.1M | 5.65 | |
| ArQule | 0.8 | $4.8M | 3.1M | 1.55 | |
| Exelixis (EXEL) | 0.5 | $3.4M | 1.0M | 3.39 | |
| OncoGenex Pharmaceuticals | 0.5 | $3.2M | 862k | 3.73 | |
| Biolinerx Ltd-spons | 0.5 | $3.1M | 1.5M | 2.08 | |
| Kalobios Pharmaceuticals | 0.4 | $2.6M | 1.2M | 2.28 | |
| Anthera Pharmaceutcls | 0.3 | $1.9M | 560k | 3.39 | |
| Achaogen | 0.3 | $1.7M | 125k | 13.96 | |
| Uniqure Nv (QURE) | 0.3 | $1.7M | 125k | 13.59 | |
| Palatin Technologies | 0.2 | $1.6M | 1.6M | 0.99 | |
| Regulus Therapeutics | 0.2 | $1.5M | 185k | 8.04 | |
| Bind Therapeutics | 0.2 | $1.5M | 116k | 13.18 | |
| Sophiris Bio | 0.2 | $1.3M | 600k | 2.24 | |
| Biota Pharmaceuticals | 0.2 | $1.2M | 436k | 2.85 | |
| Transcept Pharmaceuticals | 0.1 | $299k | 150k | 1.99 |
